Malaria Vaccine Safety and Immunogenicity Study in Healthy Adults

NCT02992119 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

193

Enrollment

OTHER

Sponsor class

Conditions

Malaria Vaccine

Interventions

BIOLOGICAL: RTS,S/AS01B Fractional dose
BIOLOGICAL: Double RTS,S/AS01E Fractional dose
BIOLOGICAL: RTS,S/AS01E Standard dose
BIOLOGICAL: RTS,S/AS01E + DHA-PIP+PQ Standard dose
BIOLOGICAL: RTS,S/AS01E Fractional dose
BIOLOGICAL: RTS,S/AS01E + DHA-PIP+PQ Fractional dose
BIOLOGICAL: RTS,S/AS01E + DHA-PIP+PQ Fractional two-dose

Sponsor

University of Oxford